3rd Quarter - Report

HUMANA, INC. for HUMANA INC

Firm
Client
Income
—
Expenses
$1,220,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

CMS-9115-P Interoperability and Patient Access Final Rule HHS ONC RIN-0955-AA01 - 21st Century Cures Interoperability and Information Blocking Final Rule H.R. 3, Elijah E. Cummings Lower Drug Prices Now Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 (116th Congress) S. 2164, Lower Cost, More Cures Act of 2021 COVID-19 Response, including COVID-19 bills legislation implementation The Senate Amendment to H.R. 133, Consolidated Appropriations Act, 2021 (surprise billing legislation implementation) H.R. 19, Lower Cost, More Cures Act of 2021 Inflation Reduction Act of 2022 (HR 5376) Public Law No. 117-169 CMS-9908-IFC Surprise Billing, Part II; Interim Final Rule with Comment Period

LobbyistCovered position, as disclosed
VERONICA JACKSON —
JEFFREY LUNGREN —
RACHEL MAGNUSON —
ALEXANDER WARE —
KEITH WAYNE ZUEGEL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS)

Bills named: S. 2543 (117th), H.R. 133 (117th), S. 2164 (117th), H.R. 5376 (117th), H.R. 3 (117th), H.R. 19 (117th)

Medicare/Medicaid MMM

COVID-19 Response, including COVID-19 bills legislation implementation Medicare Advantage Policy and Reimbursement 2023 Medicare Advantage Advance Rate Notice CMS-4192-P 2023 Medicare Care Advantage Part D Proposed Rule Medicare Part D Issues Medicaid and Dual Eligible Issues Pharmacy Reimbursement Issues Medicare Home Health Issues Prescription Drug Rebate issues, including Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021 H.R. 4074, A bill to expand the availability of supplemental benefits to certain Medicare Advantage enrollees Medicare Hospice Issues Medicare Vision, Dental & Hearing Inflation Reduction Act of 2022 (HR 5376) Public Law No. 117-169 CMS-1772-P CY 2023 Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates CMS-1771-P Hospital Inpatient Prospective Payment System for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Fiscal Year 2023 Rates CMS-1770-P Revisions to Payment Policies under the Medicare Physician Fee Schedule, Quality Payment Program and Other Revisions to Part B for CY 2023 S. 3018/H.R. 3173, Improving Seniors Timely Access to Care Act CMS-1766-P CY 2023 Home Health Prospective Payment System Rate Update; Home Health Quality Reporting Program Requirements; Home Health Value-Based Purchasing Expanded Model Requirements; and Home Infusion Therapy Services Requirements CMS-4203-NC Medicare Program; Request for Information on Medicare

LobbyistCovered position, as disclosed
VERONICA JACKSON —
JEFFREY LUNGREN —
RACHEL MAGNUSON —
ALEXANDER WARE —
KEITH WAYNE ZUEGEL —

Contacted: White House Office; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Office of Management & Budget (OMB)

Bills named: H.R. 3173 (117th), H.R. 4074 (117th), H.R. 2166 (117th), S. 3018 (117th), S. 150 (117th), H.R. 5376 (117th)

Defense DEF

COVID-19 Response, including COVID-19 bills legislation implementation TRICARE Issues NDAA Implementation Issues Military Members, Military Families, Veterans, Retirees Improving Veterans Healthcare Telehealth Value-Based Care H.R.475 - Health Care Fairness for Military Families Act of 2021 S.1972: Health Care Fairness for Military Families Act of 2021 Fiscal Year 2023 National Defense Authorization Act

LobbyistCovered position, as disclosed
VERONICA JACKSON —
JEFFREY LUNGREN —
RACHEL MAGNUSON —
ALEXANDER WARE —
KEITH WAYNE ZUEGEL —

Contacted: SENATE; Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES

Bills named: S. 1972 (117th), H.R. 475 (117th)

Taxation/Internal Revenue Code TAX

COVID-19 Response Tax Reform Implementation Issues

LobbyistCovered position, as disclosed
VERONICA JACKSON —
JEFFREY LUNGREN —
RACHEL MAGNUSON —
ALEXANDER WARE —
KEITH WAYNE ZUEGEL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; White House Office; Treasury, Dept of

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.